An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use.
暂无分享,去创建一个
Puay Hoon Tan | C. J. Lim | P. Tan | S. Wong | J. Yeong | Valerie Chew | Siew Cheng Wong | J. Iqbal | J. Lim | Jeffrey Chun Tatt Lim | Joe Poh Sheng Yeong | Chun Jye Lim | Clara Chong Hui Ong | Valerie Suk Peng Chew | Syed Salahuddin Ahmed | Jabed Iqbal | C. Ong | C. Lim
[1] John M S Bartlett,et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] I. Dawson,et al. Immunochemical studies of the endocrine cells of the gastrointestinal tract. II An immunoperoxide technique for the localization of secretin containing cells in human duodenum. , 1975, Journal of clinical pathology.
[3] Michael Neuberger,et al. Multispectral Imaging of T and B Cells in Murine Spleen and Tumor , 2016, The Journal of Immunology.
[4] P. Tan,et al. Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer , 2017, Breast Cancer Research and Treatment.
[5] Haidong Dong,et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion , 2002, Nature Medicine.
[6] Wei Huang,et al. Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression. , 2014, Human pathology.
[7] A. Bertoletti,et al. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. , 2009, Gastroenterology.
[8] J. Madore,et al. Programmed death ligand 1 expression in triple‐negative breast cancer is associated with tumour‐infiltrating lymphocytes and improved outcome , 2016, Histopathology.
[9] Pierre Hainaut,et al. Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy. , 2013, Current opinion in oncology.
[10] G. B. Pierce,et al. ENZYME-LABELED ANTIBODIES: PREPARATION AND APPLICATION FOR THE LOCALIZATION OF ANTIGENS , 1966, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[11] H. Kohrt,et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients , 2014, Nature.
[12] Y. Sun,et al. High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment , 2014, British Journal of Cancer.
[13] K. Shirouzu,et al. FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis , 2013, Molecular and clinical oncology.
[14] Stephen M. Douglass,et al. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12 , 2014, The Journal of pathology.
[15] S. Rosenberg,et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. , 2009, Blood.
[16] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[17] G. Botti,et al. Programmed Death Ligand 1 (PD-L1) Tumor Expression Is Associated with a Better Prognosis and Diabetic Disease in Triple Negative Breast Cancer Patients , 2017, International journal of molecular sciences.
[18] Anthony Rhodes,et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.
[19] A. Tzankov,et al. Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas , 2010, Disease markers.
[20] Chichung Wang,et al. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. , 2014, Methods.
[21] T. Chung,et al. Assay Format as a Critical Success Factor for Identification of Novel Inhibitor Chemotypes of Tissue-Nonspecific Alkaline Phosphatase from High-Throughput Screening , 2010, Molecules.
[22] H. Idikio. Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains. , 2009, International journal of clinical and experimental pathology.
[23] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[24] Hailing Lu. FOXP3 expression and prognosis: role of both the tumor and T cells. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Patrice Ravel,et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. , 2013, Cancer research.
[26] R. Kalluri,et al. Epithelial to Mesenchymal Transition induces cell cycle arrest and parenchymal damage in renal fibrosis , 2015, Nature Medicine.